Key D W, Bloom D A, Sanvordenker J
Department of Surgery, University of Michigan Medical Center, Ann Arbor.
Clin Pediatr (Phila). 1992 May;31(5):299-301. doi: 10.1177/000992289203100507.
A five-year experience with the vasopressin analogue desmopressin acetate (DDAVP) for nocturnal enuresis is described in 59 children. The initial starting dose of 5 micrograms at bedtime is lower than that reported in other series. Eighty-one percent of patients required 10 micrograms or less to achieve improvement or resolution of bedwetting.
